Home
About
Overview
Sharing Data
ORCID
Help
History (5)
Agent-based models in translational systems biology.
Cerebrospinal fluid and urinary biogenic amines in depressed patients and healthy controls.
Comparing the subjective, psychomotor and physiological effects of intravenous pentazocine and morphine in normal volunteers.
Diminished insulin and glucagon secretory responses to arginine in nondiabetic subjects with a mutation in the hepatocyte nuclear factor-4alpha/MODY1 gene.
Potential use of Sox9 gene therapy for intervertebral degenerative disc disease.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Potential use of Sox9 gene therapy for intervertebral degenerative disc disease.
Potential use of Sox9 gene therapy for intervertebral degenerative disc disease. Spine (Phila Pa 1976). 2003 Apr 15; 28(8):755-63.
View in:
PubMed
subject areas
Adenoviridae
Animals
Cells, Cultured
Chondrocytes
Collagen Type II
Disease Models, Animal
Drug Administration Routes
Gene Expression
Genes, Reporter
Genetic Therapy
Genetic Vectors
Green Fluorescent Proteins
High Mobility Group Proteins
Humans
Intervertebral Disc Displacement
Kidney
Luminescent Proteins
Rabbits
RNA, Messenger
SOX9 Transcription Factor
Transcription Factors
Transduction, Genetic
Treatment Outcome
authors with profiles
Rex C. Haydon
Tong-Chuan He
Purnendu Gupta